|
Gynecologic
Oncology
|
|
|
化學治療與放射線治療相關的副作用評估表關的副作用評估表
WHO (World Health Organization) Toxicity Criteria by
Grade
化學治療以 WHO
Toxicity Criteria 為主
放射治療有分急性與慢性副作用以 RTOG
Toxicity Criteria為主
WHO Toxicity Criteria
Category |
Toxicity |
Grade0 |
Grade1 |
Grade2 |
Grade3 |
Grade4 |
Haematology |
WBC (x103/l) |
4 |
3.0 - 3.9 |
2.0 - 2.9 |
1.0 - 1.9 |
< 1.0 |
Haematology |
Platelets (x103/l) |
WNL |
75.0 - normal |
50.0 - 74.9 |
25.0 - 49.9 |
< 25.0 |
Haematology |
Haemoglobin (g/dl) |
WNL |
10.0 - normal |
8.0 - 9.9 |
6.5 - 7.9 |
< 6.5 |
Haematology |
Granulocytes/ Bands (x103/l) |
2 |
1.5 - 1.9 |
1.0 - 1.4 |
0.5 - 0.9 |
< 0.5 |
Haematology |
Lymphocytes (x103/l) |
2 |
1.5 - 1.9 |
1.0 - 1.4 |
0.5 - 0.9 |
< 0.5 |
Haematology |
Haemorrhage |
none |
mild, no |
gross, 1 - 2 units transfusion per episode
|
gross, 3 - 4 units transfusion per episode
|
massive, > 4 units transfusion per episode
|
Coagulatio |
Fibrinogen |
WNL |
0.99 - 0.75 x N |
0.74 - 0.50 x N |
0.49 - 0.25 x N |
< 0.25 x N |
Coagulatio |
Prothrombin time(Quick) |
WNL |
1.01 - 1.25 x N |
1.26 - 1.50 x N |
1.51 - 2.00 x N |
> 2.00 x N |
Coagulatio |
Partial thrombo- plastin time |
WNL |
1.01 - 1.66 x N |
1.67 - 2.33 x N |
2.34 - 3.00 x N |
> 3.00 x N |
Metabolic |
Hyperglycaemia (mg/dl) |
< 116 |
116 - 160 |
161 - 250 |
251 - 500 |
> 500 or ketoacidosis |
Metabolic |
Hypoglycaemia (mg/dl) |
> 64 |
55 - 64 |
40 - 54 |
30 - 39 |
< 30 |
Metabolic |
Amylase |
WNL |
< 1.5 x N |
1.5 - 2.0 x N |
2.1 - 5.0 N |
> 5.0 x N |
Metabolic |
Hypercalcaemia (mg/dl) |
< 10.6 |
10.6 - 11.5 |
11.6 - 12.5 |
12.6 - 13.4 |
13.5 |
Metabolic |
Hypocalcaemia (mg/dl) |
> 8.4 |
8.4 - 7.8 |
7.7 - 7.0 |
6.9 - 6.1 |
6 |
Metabolic |
Hypomagnesaemia (mg/dl) |
> 1.4 |
1.4 - 1.2 |
1.1 - 0.9 |
0.8 - 0.6 |
0.5 |
Gastrointestinal |
Nausea |
none |
able to eat |
intake |
no significant |
__ |
Gastrointestinal |
Vomiting |
none |
1 episode in 24 hrs |
2 - 5 episodes in 24 hrs |
6 - 10 episodes in 24 hrs |
> 10 episodes in 24 hrs or requiring paren-
teral support |
Gastrointestinal |
Diarrhoea |
none |
increase of 2 - 3 stools / day over pre-Rx
|
increase of 4 -6 stools / day, or nocturnal
stools, or moderate cramping |
increase of 7 - 9 stools / day, or incontinence,
or severe cramping |
increase of > 10 stools / day or grossly bloody
diarrhoea, or need for paren-teral support |
Gastrointestinal |
Stomatitis |
none |
painless ulcers, erythema, or mild soreness
|
painful erythema, oedema, or ulcers but can eat
solids |
painful erythema, oedema, or ulcers and cannot
eat solids |
requires paren-teral or enteral support for
alimentation |
Liver |
Bilirubin (N = 17 μmol/L) |
WNL |
----- |
< 1.5 x N |
1.5 - 3.0 x N |
> 3.0 x N |
Liver |
Transaminase (SGOT, SGPT) |
WNL |
2.5 x N |
2.6 - 5.0 x N |
5.1 - 20.0 x N |
> 20.0 x N |
Liver |
Alk Phos or 5 nucleotidase |
WNL |
< 2.5 x N |
2.6 - 5.0 x N |
5.1 - 20.0 x N |
> 20.0 x N |
Liver |
Liver- clinical |
No change from baseline |
----- |
----- |
precoma |
hepatic coma |
Kidney, bladder |
Creatinine |
WNL |
< 1.5 x N |
1.5 - 3.0 x N |
3.1 - 6.0 x N |
> 6.0 x N |
Kidney, bladder |
Proteinuria |
No change |
1 (+) or < 0.3 g% or 3 g/L |
2 - 3 (+) or 0.3 - 1.0 g% or 3 - 10 g/L
|
4 (+) or > 1.0 g% or > 10g/L |
nephrotic syndrome |
Kidney, bladder |
Haematuria |
Negative |
microscopic only |
gross, no clots no Rx needed |
gross and clots bladder irrigation |
requires trans- fusion or cystectomy
|
Kidney, |
Weight gain/ loss |
< 5.0 % |
5.0 - 9.9 % |
10.0 -19.9 % |
20.00% |
----- |
Pulmonary |
Pulmonary |
none or no change |
asymptomatic, with abnormal- ity in PFTs
|
dyspnoea on significant exertion |
dyspnoea at normal level of activity
|
dyspnoea at rest |
Cardiac |
Cardiac arrhythmias |
none |
asymptomatic, transient, requiring no therapy
|
recurrent or persistent, no therapy required
|
requires treatment |
requires moni- toring; or hypo- tension, or
ventricular tachycardia or fibrillation |
Cardiac |
Cardiac function |
none |
asymptomatic, decline of resting ejection
fraction by less than 20 % of baseline value |
asymptomatic, decline of resting ejection
fraction by more than 20 % of baseline value |
mild CHF, responsive to therapy |
severe of refractory CHF |
Cardiac |
Cardiac ischaemia |
none |
non-specific T- wave flattening |
asymptomatic, ST and T wave changes suggesting
ischaemia |
angina without evidence of infraction
|
acute myocardial infarction |
Cardiac |
Cardiac- pericardial |
none |
asymptomatic effusion, no itervention required
|
pericarditis (rub, chest pain, ECG changes)
|
symptomatic effusion; drainage required
|
tamponade; drainage urgently required
|
Cardiac |
Hypertension |
none or no change |
asymptomatic, transient increase by greater than
20 mm Hg (D) or to > 150 / 100 if previously WNL. No treatment
required. |
recurrent or persistent increase by greater than
20 mm HG (D) or to > 150 / 100 if previously WNL. No treatment
required. |
requires therapy |
hypertensive crisis |
Cardiac |
Hypotension |
none or no change |
changes requiring no therapy (incl- |
requires fluid replacement |
requires therapy and |
requires therapy and |
Neurologic |
Neuro: sensory |
none or no change |
mild paraesthesias; loss of deep tendon reflexes
|
mild or moderate objective sensory loss moderate
paraesthesias |
severe objective sensory loss or paraesthesias
that interfere with function |
----- |
Neurologic |
Neuro: motor |
none or no change |
subjective weak- ness; no objective findings
|
mild objective weakness without significant
impair- ment of function |
objektive weak- ness with impairment of function
|
paralysis |
Neurologic |
Neuro: cortical |
none |
mild somnolence or agitation |
moderate somnolence or agitation |
severe somnolence, (>50 % waking hours),
agitation, confusion, disorientation or hallucinations
|
coma, seizures, toxic psychosis |
Neurologic |
Neuro: cerebellar |
none |
slight incoordination, dysdiadochokinesia
|
intention tremor, dysmetria, slurred speech,
nystagmus |
locomotor ataxia |
cerebellar necrosis |
Neurologic |
Neuro: mood |
no change |
mild anxiety or depression |
moderate anxiety or depression |
severe anxiety or depression |
suicidal ideation |
Neurologic |
Neuro: headache |
none |
mild |
moderate or severe but transient |
unrelenting and severe |
----- |
Neurologic |
Neuro: constipation |
none or no change |
mild |
moderate |
severe |
ileus > 96 hrs |
Neurologic |
Neuro: hearing |
none or no change |
asymptomatic, hearing loss on audiometry only
|
tinnitus |
hearing loss interfering with function but
correctable with hearing aid |
deafness not correctable |
Neurologic |
Neuro: vision |
none or no change |
----- |
----- |
symptomatic subtotal loss of vision |
blindness |
Pain |
Pain |
none |
mild |
moderate |
severe |
reg. narcotics |
Skin |
Skin |
none or no change |
scattered macular ot papular eruption or
erythema that is asymptomatic |
scattered macular or papular eruption or
erythema with pruritus or other associated symptoms |
generalised symptomatic macular, papular or
vesicular eruption |
exfoliative dermatitis or ulcerating dermatitis
|
Alopecia |
Alopecia |
no loss |
mild hair loss |
pronounced or total hair loss |
----- |
----- |
Allergy |
Allergy |
none |
transient rash, drug fever < 38oC (100.4oF)
|
urticaria, drug fever 38oC (100.4oF), mild
bronchospasm |
serum sickness, bronchospasm requiring
parenteral medication |
anaphylaxis |
Local |
Local |
none |
pain |
pain and swelling with inflammation or phlebitis
|
ulceration |
plastic surgery indicated |
Fever of unknown origin |
Fever of unknown origin |
none |
37.1 - 38.0o C 98.7o - 100.4o F |
38.1 - 40.0oC 100.5 -104oF |
> 40.0oC > 104.0oF for less than 24hrs
|
> 40.0oC (>104oF) for more than 24 hrs or
accompanied by hypotension |
Infection |
Infection |
none |
mild |
moderate |
severe |
life-threatening |
|
|
|
|
|